Expression analysis of MEF2C in 79 pediatric T-ALL samples (public dataset GSE42038) demonstrated aberrant overexpression in 19% of the patients at varying levels (Figure 1A). The gene discussed is MEF2C; the disease is acute lymphoblastic leukemia.